US5067963A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of making live autogenous skeletal replacement parts
Assignee: Washington University in St. Louis
•
Filing: 1990-08-21
•
Granted: 1991-11-26
•
Expires: 2010-08-21
Abstract
Abstract A novel method is disclosed for the manufacture of live autogenous skeletal replacement parts through muscle flap molding and osteoinduction comprising the steps of: a) forming a mold of physiologically inert support material into the shape of a replacement part for a defective skeletal site, b) placing a muscle flap into the cavity of the mold, c) thoroughly incorporating osteoinductive factor in the muscle flap, d) closing the mold, e) allowing osteogenesis to take place, and f) implanting the resulting newly formed bone into the defective skeletal site.
Inventors
- 👤 Roger K. Khouri
- 👤 A. Harri Reddi
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 05:06
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/36; A61L27/3604; A61L27/3608; A61F; A61F2/00; A61F2/02; A61F2/28; A61F2/30; A61F2/46; A61F2/4644; A61L27/14; A61L27/18; A61L27/22; A61L27/227; A61F2/3094; A61F2/30942; A61F2002/30957; A61F2002/4648; Y; Y10; Y10S; Y10S623/00; Y10S623/901
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
85 words
A method for the manufacture of live autogenous skeletal replacement parts through muscle flap molding and osteoinduction comprising the steps of: a) forming a mold of physiologically inert support material into the shape of a replacement part for a defective skeletal site, b) placing a muscle flap into the cavity of the mold, c) thoroughly incorporating osteoinductive factor in the muscle flap, d) closing the mold, e) allowing osteogenesis to take place, and f) implanting the resulting newly formed bone into said defective skeletal site.
Claim 2
Independent Claim
85 words
A method for the manufacture of live autogenous skeletal replacement parts through muscle flap molding and osteoinduction comprising the steps of: a) forming a mold of physiologically inert support material into the shape of a replacement part for a defective skeletal site, b) placing a muscle flap into the cavity of the mold, c) thoroughly incorporating osteoinductive factor in the muscle flap, d) closing the mold, e) allowing osteogenesis to take place, and f) implanting the resulting newly formed bone into said defective skeletal site.
Claim 3
Dependent Claim
24 words
The method of claim 1 in which the osteoinductive factor is osteogenin of 30-40 kDa molecular weight as determined by SDS-PAGE under non-reducing conditions.
Claim 4
Dependent Claim
16 words
The method of claim 1 in which the mold is formed of a silicone rubber material.
Claim 5
Dependent Claim
26 words
The method of claim 1 in which the muscle flap is perfused with about 0.2 μg of osteogenin for each 750-1000 mg of muscle flap tissue.
Claim 6
Dependent Claim
30 words
The method of claim 1 in which the inner surface of the mold is coated with demineralized bone matrix before placing the muscle flap into the cavity of the mold.
Claim 7
Dependent Claim
27 words
The method of claim 5 in which the mold is coated with about 25 mg of demineralized bone matrix for each 750-1000 mg of muscle flap tissue.
Claim 8
Independent Claim
138 words
A method for the manufacture of live autogenous skeletal replacement parts through muscle flap molding and osteoinduction comprising the steps of: a) forming a mold of silicone rubber into the shape of a replacement part for a defective skeletal site, b) coating the inner surface of the mold with about 25 mg of demineralized bone matrix for each 750-1000 mg of muscle flap tissue used in the next step, c) placing a muscle flap into the cavity of the mold, d) thoroughly incorporating in the muscle flap about 0.2 μg of osteogenin having a molecular weight of about 30-40 kDa as determined by SDS-PAGE under non-reducing conditions for each 750-1000 mg of muscle flap tissue, e) closing the mold, f) allowing osteogenesis to take place, and g) implanting the resulting newly formed bone into said defective skeletal site.
Claim 9
Independent Claim
138 words
A method for the manufacture of live autogenous skeletal replacement parts through muscle flap molding and osteoinduction comprising the steps of: a) forming a mold of silicone rubber into the shape of a replacement part for a defective skeletal site, b) coating the inner surface of the mold with about 25 mg of demineralized bone matrix for each 750-1000 mg of muscle flap tissue used in the next step, c) placing a muscle flap into the cavity of the mold, d) thoroughly incorporating in the muscle flap about 0.2 μg of osteogenin having a molecular weight of about 30-40 kDa as determined by SDS-PAGE under non-reducing conditions for each 750-1000 mg of muscle flap tissue, e) closing the mold, f) allowing osteogenesis to take place, and g) implanting the resulting newly formed bone into said defective skeletal site.
References Cited (Backward Citations)
US4294753A
Cited
US4761471A
Cited
US4619989A
Cited
US4455256A
Cited
US4430760A
Cited
US4440750A
Cited
US4485097A
Cited
US4434094A
Cited
US4795804A
Cited
US4526909A
Cited
US4563489A
Cited
US4620327A
Cited
US4774228A
Cited
US4789932A
Cited
US4992226A
Cited
US4857456A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-11-25 | 1995-05-27 | 1995-11-26 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-11-25 | 1999-05-27 | 1999-11-26 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-11-25 | 2003-05-27 | 2003-11-26 | $7700.00 | Window Closed / Lapsed |